ResMed Inc. (BIT:1RMD)
Italy · Delayed Price · Currency is EUR 223.40
+8.40 (3.91%)
At close: Mar 3, 2026
ResMed Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 1,486 | 1,401 | 1,021 | 897.56 | 779.44 | 474.51 |
Depreciation & Amortization | 246.2 | 235.81 | 216.21 | 197.56 | 193.84 | 191.52 |
Stock-Based Compensation | 98.97 | 91.66 | 80.18 | 71.14 | 65.26 | 63.93 |
Other Adjustments | 9.46 | 6.66 | 39.13 | -10.83 | 20.69 | 5.36 |
Change in Receivables | -87.96 | -76.68 | -134.28 | -106.51 | 19.35 | -129.2 |
Changes in Inventories | 9.2 | -80.17 | 172.2 | -248.83 | -311.68 | -21.95 |
Changes in Accounts Payable | 130.46 | 90.96 | 122.07 | 31.34 | -247.63 | 210.71 |
Changes in Other Operating Activities | 22.3 | 82.63 | -115.21 | -138.13 | -168.11 | -58.15 |
Operating Cash Flow | 1,914 | 1,752 | 1,401 | 693.3 | 351.15 | 736.72 |
Operating Cash Flow Growth | 29.68% | 25.00% | 102.11% | 97.44% | -52.34% | -8.17% |
Capital Expenditures | -122.89 | -89.87 | -99.46 | -119.67 | -134.84 | -102.71 |
Purchases of Intangible Assets | -13.54 | -10.78 | -15.4 | -14.33 | -21.2 | -14.11 |
Purchases of Investments | -10.47 | -6.42 | -12.77 | -32.23 | -20.72 | -21.79 |
Proceeds from Sale of Investments | 18.58 | 46.26 | -8.7 | 19.13 | -10.37 | 19.22 |
Payments for Business Acquisitions | -208.39 | -139.25 | -133.46 | -1,013 | -42.78 | -39.07 |
Investing Cash Flow | -269.02 | -200.05 | -269.78 | -1,160 | -229.92 | -158.46 |
Long-Term Debt Issued | - | - | 105 | 1,070 | 288 | 90 |
Long-Term Debt Repaid | -12.5 | -40 | -835 | -405 | -166 | -612 |
Net Long-Term Debt Issued (Repaid) | -12.5 | -40 | -730 | 665 | 122 | -522 |
Issuance of Common Stock | 76.94 | 74.44 | 53.09 | 49.14 | 47.38 | 37.79 |
Repurchase of Common Stock | -522.04 | -318.1 | -158.77 | -30.63 | -52.41 | -50.21 |
Net Common Stock Issued (Repurchased) | -445.1 | -243.66 | -105.67 | 18.51 | -5.02 | -12.42 |
Common Dividends Paid | -330.63 | -310.88 | -282.32 | -258.28 | -245.34 | -226.71 |
Other Financing Activities | -10.86 | -11.71 | -1.29 | -2.36 | - | -3.5 |
Financing Cash Flow | -796.58 | -606.25 | -1,119 | 422.87 | -128.36 | -764.63 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 46.23 | 25.8 | -1.72 | -2.15 | -14.43 | 18.5 |
Net Cash Flow | 895.13 | 971.09 | 10.47 | -45.82 | -21.57 | -167.88 |
Free Cash Flow | 1,792 | 1,662 | 1,302 | 573.63 | 216.31 | 634.01 |
Free Cash Flow Growth | 7.82% | 27.65% | 126.94% | 165.19% | -65.88% | -10.32% |
FCF Margin | 33.19% | 32.29% | 27.78% | 13.58% | 6.05% | 19.83% |
Free Cash Flow Per Share | 12.20 | 11.28 | 8.82 | 3.89 | 1.47 | 4.33 |
Levered Free Cash Flow | 1,759 | 1,600 | 586.76 | 1,285 | 233.02 | 171.91 |
Unlevered Free Cash Flow | 1,771 | 1,647 | 1,361 | 644.44 | 143.32 | 704.66 |
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.